Archive for April 2015
Immunexpress raising $40M; measures immune response to shave sepsis diagnostic time to one hour
Seattle diagnostics company Immunexpress is working to whittle sepsis screening time down to an hour – and is in the midst of a $40 million Series C to do so.
Read MoreImmunexpress vying for FDA clearance of its sepsis test
When it comes right down to detecting sepsis most diagnostics companies use methods to identify the pathogen. But therein lies the issue with looking for the pathogen, because it has to be in the blood sample or the fluid sample to start with, otherwise a clinician can’t find. That’s where Immunexpress (Seattle) comes in. The…
Read MoreImmunexpress to Submit Molecular ‘Immune Response’ Sepsis Assay to FDA in May
Immunexpress may finally be close to marketing a clinical test in the US. Having just wrapped up a key clinical trial of its first sepsis assay in around 200 ICU patients, the company plans to submit the test in May to the US Food and Drug Administration and hopes it can gain marketing clearance by the…
Read More